StockData
OKYONasdaqBiological Products, (No Diagnostic Substances)

OKYO Pharma Ltd

Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 20, 2026
$1.40−0.01 (-0.71%)

Close on Oct 19, 2026

Market cap
–
P/E (TTM)
–
Dividend yield
–

OKYO Pharma Ltd revenue by segment

AnnualQuarterlyTTM

No segment breakdown reported

OKYO Pharma does not break out revenue by segment, region or product in the tagged data of its filings for this period type.